Emmaus Life Sciences Price Prediction

EMMADelisted Stock  USD 0.26  0.00  0.00%   
At this time, the relative strength indicator of Emmaus Life's share price is approaching 43 suggesting that the otc stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Emmaus Life, making its price go up or down.

Oversold Vs Overbought

43

 
Oversold
 
Overbought
Emmaus Life Sciences stock price prediction is an act of determining the future value of Emmaus Life shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Emmaus Life's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Emmaus Life and does not consider all of the tangible or intangible factors available from Emmaus Life's fundamental data. We analyze noise-free headlines and recent hype associated with Emmaus Life Sciences, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Emmaus Life based on different types of headlines from major news networks to social media. Using Emmaus Life hype-based prediction, you can estimate the value of Emmaus Life Sciences from the perspective of Emmaus Life response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Emmaus Life. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Emmaus Life to buy its otc stock at a price that has no basis in reality. In that case, they are not buying Emmaus because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell otc stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Emmaus Life after-hype prediction price

    
  USD 0.26  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in population.
Intrinsic
Valuation
LowRealHigh
0.230.230.29
Details
Naive
Forecast
LowNextHigh
0.270.270.27
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.240.250.27
Details

Emmaus Life After-Hype Price Prediction Density Analysis

As far as predicting the price of Emmaus Life at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Emmaus Life or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Emmaus Life, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Emmaus Life Estimiated After-Hype Price Volatility

In the context of predicting Emmaus Life's otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Emmaus Life's historical news coverage. Emmaus Life's after-hype downside and upside margins for the prediction period are 0.26 and 0.26, respectively. We have considered Emmaus Life's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.26
0.26
After-hype Price
0.26
Upside
Emmaus Life is very steady at this time. Analysis and calculation of next after-hype price of Emmaus Life Sciences is based on 3 months time horizon.

Emmaus Life OTC Stock Price Prediction Analysis

Have you ever been surprised when a price of a OTC Stock such as Emmaus Life is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Emmaus Life backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Emmaus Life, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
0 Events / Month
5 Events / Month
In a few days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.26
0.26
0.00 
0.00  
Notes

Emmaus Life Hype Timeline

Emmaus Life Sciences is currently traded for 0.26. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Emmaus is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is expected to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Emmaus Life is about 0.0%, with the expected price after the next announcement by competition of 0.26. About 39.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.18. Emmaus Life Sciences last dividend was issued on the 18th of July 2019. The entity had 1:6 split on the 18th of July 2019. Given the investment horizon of 90 days the next expected press release will be in a few days.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in population.

Emmaus Life Related Hype Analysis

Having access to credible news sources related to Emmaus Life's direct competition is more important than ever and may enhance your ability to predict Emmaus Life's future price movements. Getting to know how Emmaus Life's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Emmaus Life may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
NRXPWNRx Pharmaceuticals 0.02 3 per month 15.84  0.03  27.27 (29.69) 100.20 
KLDOKaleido Biosciences 0.00 0 per month 0.00  0.13  50.00  0.00  4,849 
AMTIApplied Molecular Transport(0.02)1 per month 5.70  0.01  11.11 (10.34) 36.60 
SCPSScopus Biopharma 0.00 0 per month 16.27  0.01  33.33 (24.62) 94.02 
CLCSCell Source 0.00 0 per month 10.10  0.1  45.24 (22.73) 92.05 
ATRXAdhera Therapeutics 0.00 0 per month 11.49  0.03  20.00 (31.58) 77.97 
PTEPolarityte 0.00 2 per month 0.00 (0.14) 16.82 (29.29) 82.60 
ZIVOZivo Bioscience 0.04 4 per month 0.00 (0.17) 5.31 (6.67) 36.36 
ANEBAnebulo Pharmaceuticals 0.03 5 per month 0.00 (0.02) 8.85 (11.48) 76.00 
ADAGAdagene 0.02 5 per month 0.00 (0.04) 8.30 (9.52) 37.93 
ACRVAcrivon Therapeutics, Common(0.04)6 per month 0.00 (0.11) 7.66 (7.65) 22.84 
ANABAnaptysBio 0.24 7 per month 0.00 (0.15) 5.30 (7.28) 35.57 
MLYSMineralys Therapeutics, Common 0.14 8 per month 3.37  0.03  6.27 (5.79) 20.98 

Emmaus Life Additional Predictive Modules

Most predictive techniques to examine Emmaus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Emmaus using various technical indicators. When you analyze Emmaus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Emmaus Life Predictive Indicators

The successful prediction of Emmaus Life stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Emmaus Life Sciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Emmaus Life based on analysis of Emmaus Life hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Emmaus Life's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Emmaus Life's related companies.

Story Coverage note for Emmaus Life

The number of cover stories for Emmaus Life depends on current market conditions and Emmaus Life's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Emmaus Life is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Emmaus Life's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Emmaus Life Short Properties

Emmaus Life's future price predictability will typically decrease when Emmaus Life's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Emmaus Life Sciences often depends not only on the future outlook of the potential Emmaus Life's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Emmaus Life's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding49.3 M
Cash And Short Term Investments2.3 M
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Consideration for investing in Emmaus OTC Stock

If you are still planning to invest in Emmaus Life Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Emmaus Life's history and understand the potential risks before investing.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios